CIK 0000744218 · Large accelerated filer
Celldex Therapeutics, Inc.
Sign in to watch- Ticker
- CLDX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 133191702
- Phone
- 908-200-7500
- Business address
- 53 FRONTAGE ROAD, SUITE 220, HAMPTON, NJ, 08827
- Former names
- AVANT IMMUNOTHERAPEUTICS INC, T CELL SCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-15 | PEPIN RONALD SR. VP & CBO | Option exercise | +8,333 | $9.02 | $75K | 9,097 |
| 2025-12-15 | PEPIN RONALD SR. VP & CBO | Option exercise | +11,000 | $2.78 | $31K | 20,097 |
| 2025-12-15 | PEPIN RONALD SR. VP & CBO | Option exercise · Incentive Stock Option (right to buy) | −8,333 | 5,000 | ||
| 2025-12-15 | PEPIN RONALD SR. VP & CBO | Option exercise · Incentive Stock Option (right to buy) | −11,000 | 0 | ||
| 2025-12-04 | Jimenez Freddy A. SVP & GENERAL COUNSEL | Sale | −4,166 | $29.10 | $121K | 30,796 |
| 2025-11-13 | Wright Richard M. Former Officer | Option exercise | +6,876 | $9.02 | $62K | 27,709 |
| 2025-11-13 | Wright Richard M. Former Officer | Option exercise | +26,672 | $10.38 | $277K | 54,381 |
| 2025-11-13 | Wright Richard M. Former Officer | Option exercise | +15,750 | $22.48 | $354K | 70,131 |
| 2025-11-13 | Wright Richard M. Former Officer | Sale | −49,298 | $24.00 | $1.2M | 20,833 |
| 2025-11-13 | Wright Richard M. Former Officer | Option exercise · Incentive Stock Option | −6,876 | 0 | ||
| 2025-11-13 | Wright Richard M. Former Officer | Option exercise · Incentive Stock Option | −26,672 | 0 | ||
| 2025-11-13 | Wright Richard M. Former Officer | Option exercise · Incentive Stock Option | −15,750 | 7,875 | ||
| 2025-11-10 | Lawver Teri L SVP & Chief Commercial Officer | Grant or award · ISO (right to buy) | +100,000 | 100,000 | ||
| 2025-08-13 | Jimenez Freddy A. SVP & GENERAL COUNSEL | Sale | −341 | $23.95 | $8K | 35,392 |
| 2025-08-13 | Jimenez Freddy A. SVP & GENERAL COUNSEL | Sale | −430 | $25.42 | $11K | 34,962 |
| 2025-06-05 | Cavanaugh Sarah SVP OF CORP AFFAIRS & ADMIN. | Grant or award · Incentive Stock Option (right to buy) | +78,000 | 78,000 | ||
| 2025-06-05 | Crowley Elizabeth SR. VP & CPDO | Grant or award · Incentive Stock Option (right to buy) | +85,000 | 85,000 | ||
| 2025-06-05 | Heath-Chiozzi Margo SVP OF REGULATORY AFFAIRS | Grant or award · Incentive Stock Option (right to buy) | +82,000 | 82,000 | ||
| 2025-06-05 | Jimenez Freddy A. SVP & GENERAL COUNSEL | Grant or award · Incentive Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2025-06-05 | Martin Samuel Bates SVP AND CFO | Grant or award · Incentive Stock Option (right to buy) | +81,000 | 81,000 |
Page 2 of 10 · 182 trades